EUVIMEDEUVIMED entdecken
Crossref

miR-885-5p regulates fibrogenic phenotypes in TGF-β1-treated LX-2 cells via targeting NR5A2, with clinical association with MAFLD

Zihui Yu, Rong Zhou, Shunyong He

Archives of Biochemistry and Biophysics · 2027-01 · 787 · 111017

DOI: 10.1016/j.abb.2026.111017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2027-01. Verfasst von Zihui Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic-associated fatty liver disease (MAFLD) is a common chronic liver disease worldwide, with liver fibrosis serving as a major determinant of poor prognosis. While miR-885-5p shows dysregulated expression in numerous metabolic and liver disorders, its function in MAFLD has yet to be fully elucidated. The present study sought to determine the cross-sectional association between miR-885-5p and MAFLD and explore its potential role in regulating fibrogenic phenotypes in hepatic stellate cells via NR5A2 modulation, thus identifying a potential biomarker for further investigation. METHODS: A total of 102 MAFLD patients and 68 healthy controls were recruited. Serum miR-885-5p and NR5A2 were quantified and correlated with clinical indicators. A TGF-β1-induced LX-2 fibrosis model was established; after miR-885-5p inhibitor and si-NR5A2 treatment, CCK-8, oxidative stress assessment, Western blots, and dual-luciferase reporter assays were performed. RESULTS: Serum miR-885-5p levels were markedly elevated in MAFLD patients, exhibiting considerable potential as cross-sectionally associated diagnostic biomarker for this disease. Dual-luciferase reporter assays verified NR5A2 as a direct downstream target of miR-885-5p. In TGF-β1-stimulated LX-2 cells, miR-885-5p silencing significantly suppressed cell viability, oxidative stress injury, and the expression of fibrotic markers including α-SMA, COL1A1, and TIMP-1. Notably, concurrent NR5A2 knockdown partially abrogated these protective effects. CONCLUSIONS: Serum miR-885-5p is elevated in MAFLD and correlates with disease severity, showing discriminative potential for metabolic liver involvement. Mechanistically, it promotes HSC activation and fibrogenesis via NR5A2 suppression, representing a candidate therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

FibrosisMAFLDNR5A2TGF-β1microRNA

Autor:innen und Institutionen

  • Department of Bacteriology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
  • Health Care Department, General Hospital of Southern Theater Command of Chinese PLA, Guangzhou, 510010, China.
  • Gastroenterology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350004, China. Electronic address: heshunyongfz@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, Z., Zhou, R., & He, S. (2027). miR-885-5p regulates fibrogenic phenotypes in TGF-β1-treated LX-2 cells via targeting NR5A2, with clinical association with MAFLD. Archives of Biochemistry and Biophysics, 787, 111017. https://doi.org/10.1016/j.abb.2026.111017

Vancouver

Yu Z, Zhou R, He S. miR-885-5p regulates fibrogenic phenotypes in TGF-β1-treated LX-2 cells via targeting NR5A2, with clinical association with MAFLD. Archives of Biochemistry and Biophysics. 2027;787:111017. doi:10.1016/j.abb.2026.111017

BibTeX
@article{Yu2027,
  author = {Yu, Zihui and Zhou, Rong and He, Shunyong},
  title = {miR-885-5p regulates fibrogenic phenotypes in TGF-β1-treated LX-2 cells via targeting NR5A2, with clinical association with MAFLD},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2027},
  volume = {787},
  pages = {111017},
  doi = {10.1016/j.abb.2026.111017}
}
Kostenlos starten →